Literature DB >> 1910684

The SCID-hu mouse: a small animal model for HIV infection and pathogenesis.

J McCune1, H Kaneshima, J Krowka, R Namikawa, H Outzen, B Peault, L Rabin, C C Shih, E Yee, M Lieberman.   

Abstract

The SCID-hu mouse is a heterochimeric small animal model designed to support hematopoietic differentiation and function in vivo. Multiple organs of the human hematolymphoid system have been successfully engrafted into the immunodeficient C.B-17 scid scid mouse, including fetal liver, thymus, lymph node, and skin. Co-implantation of human fetal liver and human fetal thymus results in long-term, multilineage human hematopoiesis in vivo. Mature human lymphocytes within the SCID-hu mouse are phenotypically and functionally normal. HIV infection of the SCID-hu mouse reflects a tropism similar to that found in humans: only human organs with CD4+ cells are infected. Viral replication can thereafter be monitored with assays that are safe, reproducible, and quantitative. Given this small animal model, it is now possible to study systematically the infective process of HIV and to address questions about the efficacy of novel antiviral compounds or vaccines in vivo.

Entities:  

Mesh:

Year:  1991        PMID: 1910684     DOI: 10.1146/annurev.iy.09.040191.002151

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  41 in total

Review 1.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice.

Authors:  Paul W Denton; J Victor Garcia
Journal:  Trends Microbiol       Date:  2012-04-12       Impact factor: 17.079

Review 3.  Current status review: the severe combined immunodeficient (SCID) mouse: xenogeneic-SCID chimeras in the investigation of human autoimmune disease.

Authors:  P C Taylor
Journal:  Int J Exp Pathol       Date:  1992-04       Impact factor: 1.925

4.  Zidovudine after occupational exposure to HIV.

Authors:  D Nixon
Journal:  BMJ       Date:  1991-07-27

5.  Induction of primary antigen-specific immune reponses in SCID-hu-PBL by coupled T-B epitopes.

Authors:  P Ifversen; C Mårtensson; L Danielsson; C Ingvar; R Carlsson; C A Borrebaeck
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

6.  Rapid CD4(+) T-cell loss induced by human immunodeficiency virus type 1(NC) in uninfected and previously infected chimpanzees.

Authors:  F J Novembre; J de Rosayro; S Nidtha; S P O'Neil; T R Gibson; T Evans-Strickfaden; C E Hart; H M McClure
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  HIV-1 pathogenesis and therapeutic intervention in the SCID-hu Thy/Liv mouse: a model for primary HIV-1 infection in the human thymus.

Authors: 
Journal:  Rev Med Virol       Date:  1997-09       Impact factor: 6.989

Review 8.  Novel humanized murine models for HIV research.

Authors:  Paul W Denton; J Victor Garcia
Journal:  Curr HIV/AIDS Rep       Date:  2009-02       Impact factor: 5.071

Review 9.  In vivo models of human lymphopoiesis and autoimmunity in severe combined immune deficient mice.

Authors:  T S Barry; B F Haynes
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

10.  Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin.

Authors:  Atsushi Yoshida; Reiko Tanaka; Tsutomu Murakami; Yoshiaki Takahashi; Yoshio Koyanagi; Masataka Nakamura; Mamoru Ito; Naoki Yamamoto; Yuetsu Tanaka
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.